Criteria of cure and remission in Cushing's disease: An update

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 8, 2007, Pages 1362-1372

  Czepielewski, Mauro A ^a   Rollin, Guilherme A F S ^a   Casagrande, Alessandra ^a   Ferreira, Nelson P ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

ACTH; Cortisol; CRH; Cushing's disease; DDAVP; Post operative evaluation in Cushing's disease; Remission criteria; Transsphenoidal surgery

Indexed keywords

EID: 38649112952     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302007000800023     Document Type: Review

References (84)

1. Czepielewski MA, Rollin GAFS. Tratamento da Síndrome de Cushing. In: Vilar L (ed). Endocrinologia Clínica. Rio de Janeiro: Guanabara Koogan, 2006. pp. 418-35.
2. Rollin GAFS, Copstein E, Czepielewski MA. Síndrome de Cushing. In: Gross JL, Silveiro SP (eds). Rotinas Diagnósticas em Endocrinologia. Porto Alegre: ArtMed, 2004. pp. 153-8.
3. Vilar L, Coelho CE. Diagnóstico e diagnóstico diferencial da Síndrome de Cushing. In: Vilar L (ed). Endocrinologia Clínica. Rio de Janeiro: Guanabara Koogan, 2006. pp. 397-417.
4. Vilar L, Naves LA, Freitas MC, Moura E, Canadas V, Leal E, et al. Endogenous Cushing's syndrome: Clinical and laboratorial features in 73 cases. Arq Bras Endocrinol Metab 2007;51(4):566-74.
5. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, et al. Diagnosis and complications of Cushing's syndrome: A consensus statement. J Clin Endocrinol Metab 2003;88(12):5593-602.
6. nd ed. Malden: Blackwell, 2002. pp. 592-612.
7. Newell-Price J, Trainer P, Besser GM, Grossman AB. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 1998;19:647-72.
8. Nieman LK, Ilias I. Evaluation and treatment of Cushing's syndrome. Am J Med 2005;118(12):1340-6.
9. Findling JW, Raff H. Cushing's syndrome: Important issues in diagnosis and management. J Clin Endocrinol Metab 2006;91(10):3746-53.
10. Utz AL, Swearingen B, Biller BMK. Pituitary surgery and postoperative management in Cushing's disease. Endocrinol Metab Clin North Am 2005;34:459-78.
11. Fitzgerald PA, Aron DC, Findling JW, Brooks RM, Wilson CB, Forsham PH, et al. Cushing's disease: Transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. J Clin Endocrinol Metab 1982;54:413-22.
12. Timmers HJ, Van Ginneken EM, Wesseling P, Sweep CG, Hermus AR. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule. J Endocrinol Invest 2006;29(10):934-9.
13. Udelsman R, Norton JA, Jelenich SE, Goldstein DS, Linehan WM, Loriaux DL, et al. Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. J Clin Endocrinol Metab. 1987;64(5):986-94.
14. Pimentel-Filho FR. Dinâmica hipófise-adrenal durante cirurgia tranesfenoidal. In: Liberman B, Cukiert A. (eds). Neuroendocrinologia Clínica e Cirúrgica. São Paulo: Lemos Editorial, 2002. pp. 507-15.
15. Pieters GF, Hermus AR, Meijer E, Smals AG, Kloppenborg PW. Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease. J Clin Endocrinol Metab 1989;69(6):1122-6.
16. Nishizawa S, Oki Y, Ohta S, Yokota N, Yokoyama T, Uemura K. What can predict postoperative "endocrinological cure" in Cushing's disease? Neurosurgery 1999;45(2):239-44.
17. Newell-Price J. Transsphenoidal surgery for Cushing's disease: Defining cure and following outcome. Clin Endocrinol (Oxf) 2002;56:19-21.
18. Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F. Diagnosis and management of Cushing's syndrome: Results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 1999;84(2):440-8.
19. George DH, Scheithauer BW, Kovacs K, Horvath E, Young WF Jr, Lloyd RV, et al. Crooke's cell adenoma of the pituitary: An aggressive variant of corticotroph adenoma. Am J Surg Pathol 2003;27(10):1330-6.
20. Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M. Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab 1996;81(7):2647-52.
21. Robert F, Hardy J. Cushing's disease: A correlation of radiological, surgical and pathological findings with therapeutic results. Pathol Res Pract 1991;187:617-21.
22. Blevins LS Jr, Christy JH, Khajavi M, Tindall GT. Outcomes of therapy for Cushing's disease due to adrenocorticotropinsecreting pituitary macroadenomas. J Clin Endocrinol Metab 1998;83:63-7.
23. Mampalam TJ, Tyrell B, Wilson CB. Transsphenoidal microsurgery for Cushing's disease. Ann Int Med 1988;109:487-93.
24. Cannavo S, Almoto B, Dall'Asta C, Corsello S, Lovicu RM, De Menis E, et al. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas. Eur J Endocrinol 2003;149(3):195-200.
25. Pereira AM, van Aken MO, van Dulken H, Schutte PJ, Biermasz NR, Smit JW, et al. Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease. J Clin Endocrinol Metab 2003;88(12):5858-64.
26. Rollin GA, Ferreira NP, Junges M, Gross JL, Czepielewski MA. Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease. J Clin Endocrinol Metab 2004;89(3):1131-9.
27. Oldfield EH, Chrousos GP, Schulte HM, Schaaf M, McKeever PE, Krudy AG, et al. Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med 1985;312:100-3.
28. Pecori-Giraldi F, Moro M, Cavagnini F. Gender-related differences in the presentation and course of Cushing's disease. J Clin Endocrinol Metab 2003;88(4):1554-8.
29. Netea-Maier RT, van Lindert EJ, den Heijer M, van der Eerden A, Pieters GF, Sweep CG, et al. Transsphenoidal pituitary surgery via the endoscopic technique: Results in 35 consecutive patients with Cushing's disease. Eur J Endocrinol 2006;154(5):675-84.
30. Guilhaume B, Bertagna X, Thomsen M, Bricaire C, Vila-Porcile E, Olivier L, et al. Transsphenoidal pituitary surgery for the treatment of Cushing's disease: Results in 64 patients and long term follow-up studies. J Clin Endocrinol Metab 1988;66(5):1056-64.
31. Barker FGN, Klibanski A, Swearingen B. Transsphenoidal surgery for pituitary tumors in United States, 1996-2000: Mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 2003;88:4709-19.
32. Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, et al. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. J Clin Endocrinol Metab 1998;83(5):1619-23.
33. Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, et al. Transsphenoidal resection in Cushing's disease: Undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf) 1993;38(1):73-8.
34. Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF. Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) 2002;56(4):541-51.
35. Bochicchio D, Losa M, Buchfelder M. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: A retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab 1995;80(11):3114-20.
36. Acebes JJ, Martino J, Masuet C, Montanya E, Soler J. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease. Acta Neurochir (Wien) 2007;149(5):471-7.
37. Devoe DJ, Miller WL, Conte FA, Kaplan SL, Grumbach MM, Rosenthal SM, et al. Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 1997;82(10):3196-202.
38. Estrada J, Garcia-Uria J, Lamas C, Alfaro J, Lucas T, Diez S, et al. The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 2001;86(12):5695-9.
39. Yap LB, Turner HE, Adams CB, Wass JA. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: A single centre audit. Clin Endocrinol (Oxf) 2002;56(1):25-31.
40. Storr HL, Afshar F, Matson M, Sabin I, Davies KM, Evanson J, et al. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease. Eur J Endocrinol. 2005;152(6):825-33.
41. Burke CW, Adams CB, Esiri MM, Morris C, Bevan JS. Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome? Clin Endocrinol (Oxf) 1990;33(4):525-37.
42. Savage MO, Storr HL, Chan LF, Grossman AB. Diagnosis and treatment of pediatric Cushing's disease. Pituitary 2007;[Epub ahead of print].
43. Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK. Longterm impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 2006;91(2):447-53.
44. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, et al. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 1999;84:2664-72.
45. Forget H, Lacroix A, Cohen H. Persistent cognitive impairment following surgical treatment of Cushing's syndrome. Psychoneuroendocrinology 2002;27:376-83.
46. van Aken MO, Pereira AM, Biermasz NR, van Thiel SW, Hoftijzer HC, Smit JW, et al. Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab 2005;90(6):3279-86.
47. Simmons NE, Alden TD, Thorner MO, Laws ER Jr. Serum cortisol response to transsphenoidal surgery for Cushing disease. J Neurosurg 2001;95(1):1-8.
48. Esposito F, Dusick JR, Cohan P, Moftakhar P, McArthur D, Wang C, et al. Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 2006;91(1):7-13.
49. Toms GC, McCarthy MI, Niven MJ, Orteu CH, King TT, Monson JP. Predicting relapse after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 1993;76(2):291-4.
50. McCance DR, Gordon DS, Fannin TF, Hadden DR, Kennedy L, Sheridan B, et al. Assessment of endocrine function after transsphenoidal surgery for Cushing's disease. Clin Endocrinol (Oxf) 1993;38(1):79-86.
51. Graham KE, Samuels MH, Raff H, Barnwell SL, Cook DM. Intraoperative adrenocorticotropin levels during transsphenoidal surgery for Cushing's disease do not predict cure. J Clin Endocrinol Metab 1997;82(6):1776-9.
52. Boggan JE, Tyrrell JB, Wilson CB. Transsphenoidal microsurgical management of Cushing's disease. Report of 100 cases. J Neurosurg 1983;59(2):195-200.
53. Fahlbusch R, Buchfelder M, Muller OA. Transsphenoidal surgery for Cushing's disease. J R Soc Med 1986;79(5):262-9.
54. Chandler WF, Schteingart DE, Lloyd RV, McKeever PE, Ibarra-Perez G. Surgical treatment of Cushing's disease. J Neurosurg 1987;66(2):204-12.
55. Nakane T, Kuwayama A, Watanabe M, Takahashi T, Kato T, Ichihara K, et al. Long term results of transsphenoidal adenomectomy in patients with Cushing's disease. Neurosurgery 1987;21(2):218-22.
56. Schrell U, Fahlbusch R, Buchfelder M, Riedl S, Stalla GK, Muller OA. Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease. J Clin Endocrinol Metab 1987;64(6):1150-9.
57. Arnott RD, Pestell RG, McKelvie PA, Henderson JK, McNeill PM, Alford FP. A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease: Prediction of outcome. Acta Endocrinol (Copenh) 1990;123(4):423-30.
58. Tindall GT, Herring CJ, Clark RV, Adams DA, Watts NB. Cushing's disease: Results of transsphenoidal microsurgery with emphasis on surgical failures. J Neurosurg 1990;72(3):363-9.
59. Ludecke DK. Transnasal microsurgery of Cushing's disease 1990. Overview including personal experiences with 256 patients. Pathol Res Pract 1991;187(5):608-12.
60. Lindholm J. Endocrine function in patients with Cushing's disease before and after treatment. Clin Endocrinol (Oxf) 1992;36(2):151-9.
61. Ram Z, Nieman LK, Cutler GB Jr, Chrousos GP, Doppman JL, Oldfield EH. Early repeat surgery for persistent Cushing's disease. J Neurosurg 1994;80(1):37-45.
62. Bakiri F, Tatai S, Aouali R, Semrouni M, Derome P, Chitour F, et al. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: Prognosis factors and long-term follow-up. J Endocrinol Invest 1996;19(9):572-80.
63. Swearingen B, Biller BM, Barker FG 2nd, Katznelson L, Grinspoon S, Klibanski A, et al. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med 1999;130(10):821-4.
64. Buchfelder M, Fahlbusch R, Wentzlaff-Eggebert H, Brabant G, Stalla GK, Muller OA. Does an analysis of the pulsatile secretion pattern of adrenocorticotropin and cortisol predict the result of transsphenoidal surgery in Cushing's disease? J Clin Endocrinol Metab 1993;77(3):720-4.
65. Chee GH, Mathias DB, James RA, Kendall-Taylor P. Transsphenoidal pituitary surgery in Cushing's disease: Can we predict outcome? Clin Endocrinol (Oxf) 2001;54(5):617-26.
66. Imaki T, Tsushima T, Hizuka N, Odagiri E, Murata Y, Suda T, et al. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery. Endocr J 2001;48(1):53-62.
67. Shimon I, Ram Z, Cohen ZR, Hadani M. Transsphenoidal surgery for Cushing's disease: Endocrinological follow-up monitoring of 82 patients. Neurosurgery 2002;51(1):57-61; discussion 61-2.
68. Atkinson AB, Kennedy A, Wiggam MI, McCance DR, Sheridan B. Long-term remission rates after pituitary surgery for Cushing's disease: The need for long-term surveillance. Clin Endocrinol (Oxf) 2005;63(5):549-59.
69. Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, et al. Transsphenoidal microsurgery for Cushing's disease: Initial outcome and long-term results. J Clin Endocrinol Metab 2004;89(12):6348-57.
70. Chen JC, Amar AP, Choi S, Singer P, Couldwell WT, Weiss MH. Transsphenoidal microsurgical treatment of Cushing disease: Postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg 2003;98(5):967-73.
71. Czirjak S, Bezzegh A, Gal A, Racz K. Intra- and postoperative plasma ACTH concentrations in patients with Cushing's disease cured by transsphenoidal pituitary surgery. Acta Neurochir (Wien) 2002;144(10):971-7.
72. Flitsch J, Knappe UJ, Ludecke DK. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease. Zentralbl Neurochir 2003;64(1):6-11.
73. Pimentel-Filho FR, Cukiert A, Miyashita F, Huayllas MK, Knoepfelmacher M, Salgado LR, et al. Adrenocorticotropin levels do not change during early recovery of transsphenoidal surgery for ACTH-secreting pituitary tumors. J Endocrinol Invest 2001;24(2):83-7.
74. Pimentel-Filho FR, Silva ME, Nogueira KC, Berger K, Cukiert A, Liberman B. Pituitary-adrenal dynamics after ACTH-secreting pituitary tumor resection in patients receiving no steroids post-operatively. J Endocrinol Invest 2005;28(6):502-8.
75. Avgerinos PC, Chrousos GP, Nieman LK, Oldfield EH, Loriaux DL, Cutler GB Jr. The corticotropin-releasing hormone test in the postoperative evaluation of patients with Cushing's syndrome. J Clin Endocrinol Metab 1987;65(5):906-13.
76. Vignati F, Berselli ME, Loi P. Early postoperative evaluation in patients with Cushing's disease: Usefulness of ovine corticotropin-releasing hormone test in the prediction of recurrence of disease. Eur J Endocrinol 1994;130(3):235-41.
77. Barbetta L, Dall'Asta C, Tomei G, Locatelli M, Giovanelli M, Ambrosi B. Assessment of cure and recurrence after pituitary surgery for Cushing's disease. Acta Neurochir (Wien) 2001;143(5):477-81; discussion 481-2.
78. Colombo P, Passini E, Re T, Faglia G, Ambrosi B. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess. Clin Endocrinol (Oxf) 1997;46(6):661-8.
79. Colombo P, Dall'Asta C, Barbetta L, Re T, Passini E, Faglia G, et al. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease. Eur J Endocrinol 2000;143(2):227-34.
80. Dall'Asta C, Barbetta L, Bonavina L, Beck-Peccoz P, Ambrosi B. Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test. Pituitary 2004;7(3):183-8.
81. Losa M, Mortini P, Dylgjeri S, Barzaghi R, Franzin A, Mandelli C, et al. Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease. Clin Endocrinol (Oxf) 2001;55(1):61-8.
82. Valero R, Vallette-Kasic S, Conte-Devolx B, Jaquet P, Brue T. The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing's disease. Eur J Endocrinol 2004;151(6):727-33.
83. Van Aken MO, de Herder WW, van der Lely AJ, de Jong FH, Lamberts SW. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease. Clin Endocrinol (Oxf) 1997;47(2):145-9.
84. Veldman RG, Frolich M, Pincus SM, Veldhuis JD, Roelfsema F. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy. J Clin Endocrinol Metab 2000;85(11):4039-46.